Murphy & Mullick Capital Management’s CapForce IBD Breakout Opportunities ETF BOUT Stock Holding History

Murphy & Mullick Capital Management’s Portfolio BOUT Stock Details BOUT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$25.7K	Buy	655 +1	+0.2%	+$39	0.02%	369
2025 Q4	$23.7K	Hold	654	–	–	0.02%	383
2025 Q3	$25K	Hold	654	–	–	0.02%	360
2025 Q2	$23.9K	Hold	654	–	–	0.02%	355
2025 Q1	$23.7K	Buy	654 +1	+0.2%	+$39	0.02%	346
2024 Q4	$25.7K	Buy	+653	New	+$25.4K	0.02%	328

Other funds holding BOUT

CWM

Comprehensive Wealth Management Lynnwood, Washington $198M AUM 11.59% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

CMMS

Comprehensive Money Management Services Coral Gables, Florida $152M AUM 20.08% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

HCM

Hollencrest Capital Management Newport Beach, California $2.7B AUM 23.62% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Sunbelt Securities Houston, Texas $1.58B AUM 28.96% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

DRP

Decker Retirement Planning Levi, Utah $294M AUM 97.44% 1-Year Est. Return

Murphy & Mullick Capital Management's BOUT Position: Q1 2026 in Review

Murphy & Mullick Capital Management increased its CapForce IBD Breakout Opportunities ETF (BOUT) stake by 0.15% in Q1 2026, buying an estimated $39 and bringing the position to 655 shares worth $25.7K. The position accounts for 0.02% of the portfolio, ranked #369.

Murphy & Mullick Capital Management first reported a position in BOUT in Q4 2024 and has held it in 6 quarters since. 14 funds tracked by Wall St. Rank hold BOUT as of Q1 2026.

Murphy & Mullick Capital Management held 655 shares of CapForce IBD Breakout Opportunities ETF worth $25.7K as of Q1 2026.
Murphy & Mullick Capital Management bought 1 CapForce IBD Breakout Opportunities ETF share in Q1 2026, an estimated $39.
CapForce IBD Breakout Opportunities ETF made up 0.02% of Murphy & Mullick Capital Management's portfolio in Q1 2026, its #369 holding.
Murphy & Mullick Capital Management first reported a position in CapForce IBD Breakout Opportunities ETF in Q4 2024 and has held it in 6 quarters since.
14 funds tracked by Wall St. Rank held CapForce IBD Breakout Opportunities ETF as of Q1 2026.

Based on Murphy & Mullick Capital Management's 13F filing for Q1 2026, filed 17 Apr 2026.